Hepatocellular Carcinoma Recurrence as Isolated Adrenal Metastasis-Reference-Cited by-同舟云学术

Hepatocellular Carcinoma Recurrence as Isolated Adrenal Metastasis

Published:2023-06 Issue:6 Volume:10 Page:e01065
ISSN:2326-3253
Container-title:ACG Case Reports Journal
language:en
Short-container-title:ACG Case Rep J

Author:

Zeineddine Fadl A.¹,Ahmed Zunirah²,Victor David²³,Farach Andrew⁴,Divatia Mukul⁵,Kodali Sudha²³

Affiliation:

1. Department of Internal Medicine, Houston Methodist Hospital, Houston TX

2. Division of Gastroenterology and Hepatology, Houston Methodist Hospital, Houston, TX

3. Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX

4. Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX

5. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX

Abstract

ABSTRACT Hepatocellular carcinoma is the sixth most common cancer in the Western world. The most frequent sites of metastasis are lungs, lymph nodes, and bones. Risk factors for extrahepatic metastasis are advanced intrahepatic lesions, vascular invasion, elevated tumor markers, and viral hepatitis. Isolated metachronous adrenal metastasis occurring after liver transplantation is exceedingly rare.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference11 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Comparison of hepatocellular carcinoma in Eastern versus Western populations;Choo;Cancer,2016

3. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma;Uka;World J Gastroenterol,2007

4. Radiotherapy for adrenal metastasis from hepatocellular carcinoma: A multi-institutional retrospective study (KROG 13-05);Jung;PLoS One,2016

5. Management of adrenal metastasis from hepatocellular carcinoma;Momoi;Surg Today,2002